Given the success of medical cannabis, the Dutch government wants to authorize a second producer
The rapid increase in demand for medical cannabis in the Netherlands and, more broadly, across Europe has led the Dutch government to make a second medical cannabis production license available. It will issue a Europe-wide call for bids in the coming days.
An ever-increasing demand to meet
The first production license was granted 16 years ago, in 2003, to Bedrocan International, a Dutch company based in Emmeloord in the northern part of the country. Bedrocan produces five types of cannabis flowers with different CBD-to-THC ratios. Its products can be found throughout Europe in countries that have legalized medical cannabis.
Faced with a surge in domestic and international demand, the company’s production capacity is beginning to be stretched. Yet it has increased its production capacity fivefold over the past five years. It seems that this is no longer enough. After 16 years of monopoly, Bedrocan will have to contend with a rival with whom it must share its sole client: the Dutch government.
A Lucrative License
The Medical Cannabis Board (BCM), a Dutch government agency, is responsible for issuing licenses for the cultivation and production of medical cannabis. The Office also oversees the establishment of cultivation sites and handles the distribution of the crop. In fact, the agency purchases all of the medical cannabis produced and then delivers it to hospitals and pharmacies. According to a report from Prohibition Partners, the domestic market was worth 5 million euros in 2018.
About half of the stock is destined for export. The Netherlands, a pioneer in medical cannabis, exports in several European markets including Germany, Italy, Poland, Denmark, Finland, Austria, Macedonia, Norway, Switzerland, Sweden, the Czech Republic, Sweden, the United Kingdom, and Malta. As a result, the license at stake is particularly lucrative. The BCM is set to launch its call for bids very soon; it has announced that it will do so «in early June.».
CBD is said to promote athletic recovery, without improving performance
294 cannabis clubs in Chile: a booming movement with uneven distribution
Chronic Sciatica: New York Approves First Clinical Trial of a THC-Based Medication
United States: The DEA is accelerating the integration of medical cannabis at the federal level
Florida is nearing one million patients using medical cannabis
Uruguay Revives Its Plan to Allow Tourists to Legally Access Cannabis
In Brazil, researchers are developing an innovative CBD eye drop
Autism: Medical Cannabis Is Linked to Reduced Anxiety
The $28 billion U.S. hemp market remains under threat
Jamaica Eases Small Farmers' Access to the Cannabis Market
-
Business5 days agoThe legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis and driving4 weeks ago
Cannabis and CBD: French Drivers Can Now Lose Their License Even Without a Positive Test Result
-
Cannabis in France2 weeks agoWhich countries legalized medical cannabis before France?
-
Business2 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in the Netherlands4 weeks ago
One year after the launch of the Dutch cannabis experiment, the first trends are emerging
-
Cannabis in Thailand2 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis in France4 weeks ago
French medical cannabis remains stalled at the Ministry of Health
-
Cannabis in Argentina3 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
You must be logged in to post a comment Login